Market: NASD |
Currency: USD
Address: 2451 Bert Dr.
Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
Show more
📈 Alpha Teknova, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$10.00
-
Upside/Downside from Analyst Target:
118.82%
-
Broker Call:
8
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
25-50%
-
Revenue Growth Range (1Y):
10-25%
-
Upcoming Earnings Date:
2025-11-07
-
EPS Estimate:
-0.16
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Alpha Teknova, Inc.
Date | Reported EPS |
---|
2025-11-06 (estimated upcoming) | - |
2025-08-07 | -0.07 |
2025-05-08 | -0.09 |
2025-03-04 | -0.11 |
2024-11-07 | -0.15 |
2024-08-13 | -0.13 |
2024-05-13 | -0.2 |
2024-03-11 | -0.2 |
2023-11-09 | -0.26 |
2023-08-10 | -0.18 |
2023-05-11 | -0.31 |
2023-03-15 | -0.47 |
2022-11-09 | -0.22 |
2022-08-10 | -0.22 |
2022-05-12 | -0.2 |
2022-03-15 | -0.13 |
2021-11-12 | -0.1 |
2021-08-11 | -0.45 |
📰 Related News & Research
No related articles found for "alpha teknova".